Search

for
Search:

Research

5 / 826 results

The Inhibition Activity of Tannin on the Formation of Mono-Species and Polymicrobial Biofilm by Escherichia Coli, Staphylococcus Aureus, Pseudomonas Aeruginosa, and Candida Albicans

research The Inhibition Activity of Tannin on the Formation of Mono-Species and Polymicrobial Biofilm Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans

17 citations , July 2019 in “Majalah Obat Tradisional”

Tannin effectively inhibits and degrades biofilms from certain bacteria and fungi.

Programmable Viscoelastic Hydrogels Exhibit Antimicrobial and Regenerative Properties to Promote Cell Migration, Wound Healing, and Tissue Remodeling

research Programmable viscoelastic hydrogels exhibit antimicrobial and regenerative properties to promote cell migration, wound healing, and tissue remodeling

April 2026 in “Microsystems & Nanoengineering”

HA-gel-dex hydrogels help heal wounds and regenerate tissue effectively.

research Multi-Approach Assessment of Albizia saponaria Bioactivity Against Dandruff-Related Bacteria and Fungi

March 2026 in “Journal of Hunan University Natural Sciences”

Albizia saponaria stem bark shows promise as a natural antidandruff treatment.

research Fucoidan-derived carbon dots against Enterococcus faecalis biofilm and infected dentinal tubules for the treatment of persistent endodontic infections

61 citations , July 2022 in “Journal of Nanobiotechnology”

Fucoidan-derived carbon dots can effectively treat root canal infections by killing bacteria and are safer than traditional disinfectants.

research Repurposing Finasteride as a quorum sensing inhibitor in Pseudomonas aeruginosa

May 2025 in “Zagazig Journal of Pharmaceutical Sciences/Zagazig Journal of Pharmaceutical Science”

Finasteride may help treat Pseudomonas aeruginosa infections by reducing its harmful activities.

View more "biofilm inhibition" in research →

Community Join

1 / 1000+ results

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

in Research/Science 89 upvotes 2 years ago

Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.

View more "biofilm inhibition" in community →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →